Kate Gunther

ORCID: 0000-0003-1641-1288 · 5 papers in corpus
other 2026
Human Reproduction ·doi:10.1093/humrep/deaf230

STUDY QUESTION: Can patient-derived organoid models be reliably established from diverse surgical phenotypes of endometriosis, and how do clinical factors such as hormonal treatment affect their growth success and morphology? SUMMARY ANSWE…

lab-animal 2026
·doi:10.26190/unsworks/32159

Endometriosis is a chronic, inflammatory condition causing debilitating pain, fatigue and subfertility in an estimated 190 million people worldwide. Currently recognised as only one disease, endometriosis is defined by the presence of lesio…

lab-animal 2025
Frontiers in pharmacology ·doi:10.3389/fphar.2025.1716062

BACKGROUND: Endometriosis is a chronic, heterogeneous disease with limited non-hormonal treatment options. Drug repurposing provides an accelerated route to identify safe, tolerable, and potentially effective therapies for endometriosis. Re…

review 2025
eLife ·doi:10.7554/elife.103825

As a heterogenous disease with likely multiple pathogeneses and as-yet-undefined subtypes, progress in endometriosis treatment is currently limited by a lack of appropriate models and cohorts for research. Almost half of all publicly availa…

review 2024
Current opinion in obstetrics & gynecology ·doi:10.1097/gco.0000000000000983

PURPOSE OF REVIEW: While laparoscopic surgery plays a key role in the management of endometriosis, symptoms commonly recur, and repeat surgery comes with increased risk. Medical management, including hormonal and nonhormonal treatment, is v…